Inventor · disambiguated record
Michael Diamond
Also filed as: DIAMOND MICHAEL · DIAMOND MICHAEL S
10 granted patents·11 pending applications·114 citations·filing 1990–2025
85Inventor score
Files withWASHINGTON UNIVERSITY ST LOUIS7UNIV WASHINGTON6BLOOD RES CENTER2DIAMOND MICHAEL2SOUTHERN RES INST2
Top patents by PatentIndex Score
21 records- 0187US5288854AFunctional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1BLOOD RES CENTER·Filed 1990·Granted Feb 22, 1994·79 cites·5 claims
- 0278US7527973B2Antibodies against West Nile Virus and therapeutic and prophylactic uses thereofUNIV WASHINGTON·Filed 2005·Granted May 5, 2009·4 cites·39 claims
- 0376US5877295AAntibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogenBLOOD RES CENTER·Filed 1995·Granted Mar 2, 1999·29 cites·5 claims
- 0474US10060924B2Distinguishing flavivirus infection using a recombinant mutant envelope proteinFRAUNHOFER GES FORSCHUNG·Filed 2014·Granted Aug 28, 2018·2 cites·20 claims
- 0570US2024116972A16-aza-nucleoside prodrugs as antiviral agents for treating virus infectionsSOUTHERN RES INST·Filed 2023·Application pending·0 cites
- 0665US7981422B2Antibodies against West Nile Virus and therapeutic and prophylactic uses thereofUNIV WASHINGTON·Filed 2009·Granted Jul 19, 2011·0 cites·3 claims
- 0763US11858956B26-aza-nucleoside prodrugs as antiviral agents for treating virus infectionsSOUTHERN RES INST·Filed 2021·Granted Jan 2, 2024·0 cites·18 claims
- 0860US2024124553A1Compositions and methods for inhibition of alphavirus infectionWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 0960US2025109199A1Compositions and methods for vldlr-based decoy receptors against alphavirusesDIAMOND MICHAEL·Filed 2024·Application pending·0 cites
- 1058US2022340658A1NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOFUNIV WASHINGTON·Filed 2022·Application pending·0 cites
- 1157US2023227848A1Coronavirus vaccine constructs and methods of making and using sameWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Application pending·0 cites
- 1254US2023346919A1Sars cov-2 vaccines and high throughput screening assays based on vesicular stomatitis virus vectorsWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Application pending·0 cites
- 1352US12448415B2Compositions and methods for inhibition of alphavirus infectionWASHINGTON UNIVERSITY ST LOUIS·Filed 2019·Granted Oct 21, 2025·0 cites·20 claims
- 1450US2022017604A1ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIESUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1547US11834494B2Antibodies to zika virus and methods of use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2017·Granted Dec 5, 2023·0 cites·8 claims
- 1647US2023183338A1Compositions and methods for inhibiting viral recognition sitesWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Application pending·0 cites
- 1746US2025243251A1Compositions and methods for targeting mxra8 to treat obesity and associated metabolic diseasesBRESTOFF PARKER JONATHAN R·Filed 2025·Application pending·0 cites
- 1844US7498419B2Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibodyUNIV WASHINGTON·Filed 2005·Granted Mar 3, 2009·0 cites·1 claims
- 1943US12274725B2Zika virus strains for treatment of gliomaWASHINGTON UNIVERSITY ST LOUIS·Filed 2018·Granted Apr 15, 2025·0 cites·4 claims
- 2041US2017101642A1Methods of inhibiting viral replication comprising the signal peptidase complexUNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 2139US2012076758A1Antibodies against west nile virus and therapeutic and prophylactic uses thereofDIAMOND MICHAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Diamond files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →